Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients. Founded in 2017, Everest Medicines is backed by investors that include RA Capital Management, Janus Henderson Investors, Hillhouse Capital Group, Decheng Capital, and Rock Springs Capital and is headquartered in New York.